Aedifica NV/SA (AED.BR)
- Previous Close
66.90 - Open
66.55 - Bid --
- Ask --
- Day's Range
65.10 - 67.00 - 52 Week Range
54.00 - 70.70 - Volume
112,158 - Avg. Volume
88,374 - Market Cap (intraday)
3.116B - Beta (5Y Monthly) 0.97
- PE Ratio (TTM)
16.23 - EPS (TTM)
4.04 - Earnings Date Jul 30, 2025
- Forward Dividend & Yield 3.90 (5.83%)
- Ex-Dividend Date May 15, 2025
- 1y Target Est
72.00
Aedifica is a regulated real estate company under Belgian law specializing in European healthcare real estate and more particularly in healthcare real estate elderly people. Aedifica has developed a portfolio of more than 600 sites in Belgium, Germany, the Netherlands, the United Kingdom, Finland, Ireland and Spain, worth more than 6.1 billion. Aedifica is listed on Euronext Brussels (2006) and Euronext Amsterdam (2019) and is identified by the following codes: AED; AED:BB (Bloomberg); AOO.BR (Reuters). Since 2020, Aedifica has been part of the BEL20, the main stock market index of EuronextBrussels. In addition, since 2023, Aedifica has been part of the BEL ESG, the index that tracks the most performing well on ESG criteria. Aedific is part of the ERRA, StoxxEurope600 and GPR. Its market capitalization was approximately 3.3 billion as of April 29, 2025.
www.aedifica.eu129
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: AED.BR
View MorePerformance Overview: AED.BR
Trailing total returns as of 5/12/2025, which may include dividends or other distributions. Benchmark is BEL 20 (^BFX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AED.BR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AED.BR
View MoreValuation Measures
Market Cap
3.18B
Enterprise Value
5.53B
Trailing P/E
16.56
Forward P/E
13.33
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.85
Price/Book (mrq)
0.86
Enterprise Value/Revenue
15.37
Enterprise Value/EBITDA
19.48
Financial Highlights
Profitability and Income Statement
Profit Margin
53.63%
Return on Assets (ttm)
2.96%
Return on Equity (ttm)
5.22%
Revenue (ttm)
357.97M
Net Income Avi to Common (ttm)
191.99M
Diluted EPS (ttm)
4.04
Balance Sheet and Cash Flow
Total Cash (mrq)
51.88M
Total Debt/Equity (mrq)
67.24%
Levered Free Cash Flow (ttm)
--